Rheumatoid Arthritis — Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis
Citation(s)
A Randomised, Double Blind, Placebo-controlled, Multiple Dose, Dose-escalation, Phase 1 Trial of Anti-IL-20 in Subjects With Rheumatoid Arthritis